| 000 | 02731cam a2200325 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 180923s2018 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.05.Ph.D.2018.El.E | ||
| 100 | 0 | _aElsayed Ibrahim Younes | |
| 245 | 1 | 0 |
_aEndovascular management of chronic cerebrospinal venous insufficiency in multiple sclerosis / _cElsayed Ibrahim Younes ; Supervised Hussein Mahmoud Khairy , Mohamed Ibrahim Sharkawy , Maciej Zarebinski |
| 246 | 1 | 5 | _aدور القسطرة التدخلية فى علاج حالات القصور الوريدية المزمن للنخاع الشوكى و الدماغ الناتج عن التصلب المعتدد |
| 260 |
_aCairo : _bElsayed Ibrahim Younes , _c2018 |
||
| 300 |
_a102 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Cardiothoracic Surgery | ||
| 520 | _aObjective: To treat venous drainage abnormality in our patients without interference with their medical treatment and to detect efficacy, safety and durability of endovascular intervention in these patient. Design: Retrospective study. Methods: Our study included 198 patients who were primary diagnosed with MS and were complaining of chronic fatigue. After accurate assessment of these patients by history taking and neurological examination, and sufficient imaging techniques were done, the diagnosis of CCSVI was overt and a decision for a liberation therapy was taken. A total number of 198 MS symptomatic patients were followed up after having endovascular therapy to their established vascular lesions using FSS scoring system compared with a baseline FSS to detect the response to fatigue improvement as well as the patency of the intervention that was held. Results: Patency percentage in our study was after one month (83.8%) , 6 months (78.3%) and 1 year (74.7%). Conclusion: To conclude our results observed in a large cohort of MS patients support the view that endovascular treatment can expose patients to severe albeit relatively rare adverse events. However the role of CCSVI in MS pathogenesis has not been confirmed. We observed an improvement in FSS and its, impact on chronic fatigue status of the patient | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aChronic cerebrospinal venous insufficiency | |
| 653 | 4 | _aEndovascular intervention | |
| 653 | 4 | _aMultiple sclerosis | |
| 700 | 0 |
_aHussein Mahmoud Khairy , _eSupervisor |
|
| 700 | 0 |
_aMaciej Zarebinski , _eSupervisor |
|
| 700 | 0 |
_aMohamed Ibrahim Sharkawy , _eSupervisor |
|
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c67620 _d67620 |
||